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Background: The lung microbiome of healthy individuals frequently harbors oral organisms. Despite evidence that
microaspiration is commonly associated with smoking-related lung diseases, the effects of lung microbiome
enrichment with upper airway taxa on inflammation has not been studied. We hypothesize that the presence of
oral microorganisms in the lung microbiome is associated with enhanced pulmonary inflammation. To test this, we
sampled bronchoalveolar lavage (BAL) from the lower airways of 29 asymptomatic subjects (nine never-smokers, 14
former-smokers, and six current-smokers). We quantified, amplified, and sequenced 16S rRNA genes from BAL
samples by qPCR and 454 sequencing. Pulmonary inflammation was assessed by exhaled nitric oxide (eNO), BAL
lymphocytes, and neutrophils.
Results: BAL had lower total 16S than supraglottic samples and higher than saline background. Bacterial communities
in the lower airway clustered in two distinct groups that we designated as pneumotypes. The rRNA gene
concentration and microbial community of the first pneumotype was similar to that of the saline background. The
second pneumotype had higher rRNA gene concentration and higher relative abundance of supraglottic-characteristic
taxa (SCT), such as Veillonella and Prevotella, and we called it pneumotypeSCT. Smoking had no effect on pneumotype
allocation, α, or β diversity. PneumotypeSCT was associated with higher BAL lymphocyte-count (P= 0.007), BAL
neutrophil-count (P= 0.034), and eNO (P= 0.022).
Conclusion: A pneumotype with high relative abundance of supraglottic-characteristic taxa is associated with
enhanced subclinical lung inflammation.
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The gut microbiome modulates host mucosal immune re-
sponse [1,2]. In contrast, despite emerging data on airway
microbiota, little is known about the role of the lung
microbiome in modulating pulmonary mucosal immune
response. Along the human airways, structures above the
vocal cords are exposed to high bacterial burden produ-
cing contamination of lower airway samples with oropha-
ryngeal secretions [3,4]. Classical culture techniques fail to* Correspondence: Leopoldo.Segal@nyumc.org; Michael.Weiden@nyumc.org
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reproduction in any medium, provided the orfully describe microbial communities of the lower airways
due to difficulties in growing fastidious bacteria, thus iden-
tification using marker gene sequencing is a more promis-
ing approach [5-11]. Such studies identified bacterial
rRNA genes of oral cavity anaerobes such as Prevotella
and Veillonella in the lower airways of normal individuals
[6,8,12-16].
Microaspiration of small volumes of oropharyngeal se-
cretions occurs in healthy people [17]. The risk for
microaspiration is increased in smoking-related lung dis-
ease due to reduced coordination of breathing with
swallowing and gastro-esophageal reflux [18,19]. Both
microaspiration and impaired mechanical clearance in
smokers may lead to increased lower airway colonizationtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ate to severe chronic obstructive pulmonary disease
(COPD), the lung microbiome is enriched with bacteria or
bacterial products common to the oral cavity [7,9,20,21].
However, these studies have focused on advanced COPD
patients, in whom frequent antibiotic and corticosteroid
use may affect the bacterial communities of the lower air-
ways. Studies of early disease and asymptomatic cases
would avoid these potential confounding effects.
Increased toll-like receptor signaling has been associated
with pulmonary inflammation in advanced COPD, offer-
ing a mechanisms by which microbial inhabitants in the
lung might be relevant for the development of smoking-
related lung injury [22,23]. Furthermore, randomized clin-
ical trials provide indications that antibiotics, especially
macrolides, may reduce COPD exacerbations [24,25].
However, it is unclear whether the beneficial effect is due
to the antibiotic or to the anti-inflammatory properties of
these drugs. An in-depth understanding of the lung
microbiome and its association with mucosal inflamma-
tory response is needed to understand potential mecha-
nisms of lung mucosal immune regulation. Here, we
hypothesized that the enrichment of the lung microbiome
of asymptomatic subjects with supraglottic-characteristic
taxa is associated with lung inflammation. To avoid poten-
tial confounders, we selected asymptomatic smokers and
never-smokers with preserved lung function and no recent




We enrolled 29 asymptomatic subjects(nine never-
smokers, 14 former-smokers, and six current-smokers)
for research bronchoscopy. All participants signed in-
formed consent to take part in this study and the re-
search protocol was approved by the human subjects
review committees of New York University and by Bellevue
Hospital Center (New York, NY) institutional review
boards. For all participants, exclusion criteria were:
FEV1<70%; recent treatment with antibiotics or steroids
in the prior 3 months; cardiovascular disease (abnormal
EKG, known or suspected coronary artery disease, or
congestive heart failure); diabetes mellitus; renal or liver
disease; lung cancer; heavy alcohol use (>6 beers daily).
During the week prior to bronchoscopy, all participants
underwent research pulmonary function testing for
physiologic phenotyping, which included spirometry,
lung volumes, diffusion, impulse oscillometry (IOS), and
exhaled nitric oxide (eNO) as a non-invasive measure of
airway inflammation [26]. In eight participants, eNO
could not be reliably measured due to high levels of am-
bient NO that was associated with inability to identify a
clear plateau on the exhaled NO vs. time tracing.Bronchoalveolar lavage
For all 29 participants, we used a nasal approach to per-
form research bronchoscopy. Since we previously observed
low bacterial loads in nasal brushing [27], we used an opti-
mized nasal bronchoscopy in an attempt to minimize the
potential for contamination of the bronchoscope channel
with upper airway microbiota. Given the concern for po-
tential carry-over of upper airway microbiome to the lower
airways, we avoid suctioning until the scope was in pos-
ition for sampling. If during bronchoscopy, visualization
was obscured, we instilled saline through the bronchoscope
channel to clear the optics. In a subgroup of 15 partici-
pants, we used two bronchoscopes to evaluate potential
carry-over. In this subgroup, we obtained a background
sample from sterile saline and sterile normal saline passed
through the bronchoscope channel. We then passed the
first bronchoscope until vocal cords were visualized to ob-
tain a supraglottic sample. The second bronchoscope was
passed to obtain BAL in two different segments. The initial
BAL was from a segment of the left lung (lingula) and the
second BAL was from a segment of the right lung (right
middle lobe, Additional file 1: Figure S1). We used three al-
iquots of 50 mL of saline for each BAL. On average, 50% of
the instilled volume was recovered. The BAL samples were
immediately placed on ice and processed within 30 min of
acquisition. Total cell count and BAL cell differentials (500
cells counted) were performed to assess counts of macro-
phages, lymphocytes, and neutrophils. BAL fluid aliquots
were frozen at −80°C for DNA isolation.
Bacterial DNA quantification and 454 pyrosequencing
DNA was isolated from acellular BAL fluid after centrifu-
gation at 500 g for 10 min at 4°C. Three methods were
used to ensure uniform bacterial lysis: a freeze-thaw cycle,
lysozyme, and a 56°C heat step at the beginning of the
DNA isolation process. DNA was then extracted with an
ion exchange column (Qiagen). Total bacterial and human
DNA levels were determined by quantitative PCR (qPCR).
We performed high-throughput sequencing of the bacter-
ial 16S rRNA gene using the Roche 454 amplicon sequen-
cing protocol. Each sample was individually barcoded
using a unique 12nt sequence during amplification of the
V1-V2 regions of the 16S gene [28]. Further details de-
scribed in Additional file 2 on line supplement.
Upstream informatics analysis of the 16S sequences
The obtained 16S rRNA sequences were analyzed using
the Quantitative Insights into Microbial Ecology (QIIME)
pipeline for analysis of community sequence data [29]. Pro-
cessing consisted of the following steps: (1) demultiplexing
and filtering of short (<150 nt) and low quality reads; (2)
de novo clustering of the sequences into operational taxo-
nomic units (OTUs) with the UCLUST program using a
97% similarity threshold [30]; (3) taxonomical assignment
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bootstrap confidence on a selected representative sequence
from each OTU; (4) alignment of representative sequences
using PyNAST [32] with the Greengenes core-set align-
ment template; (5) phylogenetic tree reconstruction from
the representative sequences for each OTUs using the
FASSTTREE program [33]; and (6) UniFrac distance calcu-
lations [34]. For each sample, the proportion of reads at
the OTU or genus levels was used as a measure of the rela-
tive abundance of each type of bacteria in a specimen. The
exact commands run are available in the Supplement.Table 1 Demographic, pulmonary functional, and BAL cell
differential in 29 participants








Pack/year (Smokers) 43 (30–50)
PFT
Spirometrya
FVC (% Predicted) 97 (85–104)
FEV1 (% Predicted) 94 (86–104)
FEV1/VC 73.4 (70.0-83.4)
Lung volumes
TLC (% Predicted) 102 (92–114)
FRC (% Predicted) 90 (94–107)
RV/TLC 0.32 (0.25-0.38)
DLCO (% Predicted) 91 (80–105)Univariate analysis of association between microbiome
and immunological phenotype
The absolute OTU sequence counts were normalized to
obtain the relative abundances of the microbiota in each
sample. These relative abundances at 97% OTU similarity
and each of the five higher taxonomic levels (phylum,
class, order, family, genus) were tested for univariate asso-
ciations with clinical variables. To decrease the number of
features, we only focused on major taxa and OTUs, de-
fined as those having mean relative abundance >1% in at
least one sample.
Since the distributions of microbiome data are non-
normal, and no distribution-specific tests are available, we
used non-parametric tests of association. For association
with discrete factors, we used either the Mann–Whitney
test (in the case of two categories) or the Kruskal Wallis
ANOVA (in case of >2 categories). For tests of association
with continuous variables, we used non-parametric
Spearman correlation tests. False discovery rate (FDR) was
used to control for multiple testing [35]. Weighted
UniFrac was used to measure β diversity of bacterial com-
munities and to perform principal coordinate analysis
(PCoA) [36]. We used the ade4 package in R to PCoA on
weighted Unifrac distances [37]. To avoid negative eigen-
values in the analysis, we used the Cailliez method to con-
vert the weighted Unifrac distance matrix into a closest
corresponding matrix with Euclidean properties, which was
further used for PCoA [38]. Hierarchical clustering on the
relative abundance profiles was used to establish deep
branching, which was interpreted as evidence for distinct
pneumotypes.IOS (R5cmH2O/L/s) 3.0 (2.5-3.4)






Data presented as % or Median (IQR).
aData based on NHANES predicted values.Classification of streptococcus OTUs
For classification of Streptococcus OTUs, 16S rRNA se-
quences were aligned to the Greengenes database using
online Blast tool (http://greengenes.lbl.gov/cgi-bin/nph-
blast_interface.cgi). Top hits were retained. A perfect
match was used for final classification if found, otherwise
top hit is reported. In case two species we found more
than once, both are reported.Results
Clinical phenotype
Table 1 shows demographics, clinical characteristics, pul-
monary function, and BAL cell counts for the 29 partici-
pants of this cohort. Enrolled subjects had normal FEV1
(median (IQR) = 94(86–104)% predicted) and FVC (97
(85–104)% predicted), and normal or mild obstruction as
quantified by FEV1/VC (73.4 (70.0-83.4)). Total airway re-
sistance as assessed by IOS also was in the normal range
(R5 = 3.0(2.5-3.4) cmH2O/L/s). Diffusion was normal (91
(80–105)% predicted). Exhaled NO ranged from normal to
elevated (range, 6.9-46.3 ppb). BAL cell differentials were
normal with major predominance of alveolar macrophages
and no neutrophilia or eosinophilia. In total, these data
show that our cohort of asymptomatic subjects had no
major pulmonary function abnormalities or obvious clin-
ical evidence of disease.
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We next examined bacterial load in the upper airways,
lower airways, and background. Supraglottic samples had
the highest 16S rRNA gene concentration (3,237,500
(276,625-6,262,500) copies/μL, Figure 1). 16S concentra-
tions in BAL were approximately 50-fold lower (68,875
(29,475-183,312) copies/μL, P<0.001). Despite extensive
overlap in bacterial load between background and BAL
samples, background samples had lower 16S rRNA gene
concentration (41,195 (18,035-79,875) copies/μL, P= 0.018).
After trimming and quality control filtering, we obtained
641,847 rDNA sequences.
454 sequencing yield no significant difference in the
number of reads per sample between rRNA obtained from
background, BAL, and supraglottic specimens (median =
6,116, 5,532, and 7,961 high quality reads per sample, re-
spectively, P= 0.12). The number of OTUs observed at
97% homology was significantly lower in background sam-
ples (93 (79–112)) compared with BAL (136 (98–158),
P<0.001) and supraglottic samples (112 (102–140),
P= 0.004).
To ensure that research bronchoscopy did not system-
atically carry-over supraglottic secretions into the lower
























Figure 1 Comparison of bacterial loads in background, BAL,
and supraglotic samples. Samples from background were
obtained from either sterile saline (open square) or from sterile
saline flushed through bronchoscope (closed square) and samples
from BAL (open circles for never-smokers and closed circles for
smokers) and supraglotic (open triangles for never-smokers and
closed triangles for smokers) were obtained via bronchoscopy as
described (see Additional file 1: Figure S1 for details). To detect
bacterial load, universal primers for bacterial 16S rRNA were used in
combination with a TaqMan Probe. Differences in bacterial loads
were evaluated using Mann–Whitney U test.from 15 subjects (three never-smokers and 12 smokers)
from the supraglottic area, with the first BAL obtained
from a segment in the lingula and the second BAL
obtained from a right middle lobe segment. UniFrac dis-
tances were calculated between supraglottic and both first
and second BAL (Figure 2). There were no significantly dif-
ferent UniFrac distances to supraglottic microbiome
between first and second BAL, providing evidence that
systematic carry-over did not occur. Analysis using
unweighted UniFrac analysis yielded similar results. Figure
3 shows data from the 15 patients with complete
supraglottic, first BAL, and second BAL data. The relative
abundance of highly represented taxa in the supraglottic
(Prevotella and Veillonella) and saline background
(Staphylococcus and Propionibacterium) are shown in the
bar graph with 16S rRNA copies/mL and Unifrac distance
shown below each sample. There was no consistent ‘dilu-
tion’ of bacterial load and/or relative abundances of
supraglottic taxa in subsequent BAL samples. As an ex-
ample, in case S10, the first BAL had lower relative abun-
dance of Prevotella and Veillonella and lower total
bacterial load by qPCR (6,902 copies/mL) than the
supraglottic sample (bacterial load = 34,250,000 copies/
mL). Compared to first BAL, the second BAL hadFigure 2 Evaluation ofcarry-over of supraglottic microbiome
compared with first and second BAL. To evaluate carry-over of
supraglotic-characteristic taxa to the lower airways, we evaluated the
microbiome of the first and second BAL return in 15 cases where a
separate bronchoscope was used to obtain a supraglotic sample
(see Additional file 1: Figure S1 for details). Paired comparison of
UniFrac distances between supraglottic and first BAL samples
compared with supraglottic and second BAL samples
(Wilcoxon rank-sum test).
Figure 3 Comparison of supraglottic bacterial communities with first and second BAL microbiome. Relative abundances of Veillonella,
Prevotella, Propionibacterium, and Staphylococcus in 15 subjects with paired supraglottic (S), first BAL (1), and second BAL (2). Veillonella and
Prevotellaare the two most abundant taxa in supraglottic samples while Propionibacterium and Staphylococcus are the two most abundant taxa in
background. UniFrac distance to supraglottic and bacterial load adjusted per mL of BALF (log10 16S qPCR) are shown below the bar graph of
relative abundance. Overall, first BAL is not consistently closer to supraglottic than second BAL.
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(total bacterial load 103,300 copies/mL). Since the bron-
choscope channel was not in contact with the upper air-
way between the first and second BAL, the increased
relative abundance of Prevotella/Veillonella and total
bacterial load between the first and second BAL in
this example could not have been due to carry-over of
supraglottic secretions contaminating the bronchoscope.
From these observations, we conclude that enrichment of
lower airway microbiome with supraglottic-characteristic
taxa (SCT) most likely results from microaspiration, rather
than from bronchoscopic carry-over.
Distinct pneumotypes in the lung microbiome
We next asked whether distinct microbiomes could be
identified in the lower airways. We used unsupervised
hierarchical clustering to assess the structure of the
microbiome in the background, supraglottic, and BAL
samples. Background sterile saline contained high rela-
tive abundances of Propionibacterium, Staphylococcus,
Corynebacterium, Stenotrophomonas, and Pseudomonas
(Figure 4, panel A). Supraglottic samples contained
high relative abundances of Prevotella, Veillonella,
Streptococcus, Fusobacterium, and Porphyromonas.
PCoA of weighted UniFrac distances confirms that the
supraglottic and background samples are distinct (panel
B). Similar results were found when unweighted
UniFrac was used (data not shown).Unsupervised hierarchical clustering of BAL samples
exhibited deep branches into two distinct clusters that
we called ‘pneumotypes’ (Figure 4, panel C). The first
pneumotype is similar to background samples with high
relative abundance of Propionibacterium (panel C). This
similarity to background microbiome makes it difficult to
determine presence of unique lung taxa and therefore we
labeled it undetermined pneumotype (pneumotypeUN).
This pneumotype was present in 12/20 (60%) smokers
and 5/9 (55%) never-smokers. PCoA of weighted UniFrac
distances shows that BAL samples characterized as
pneumotypeUN were in similar spatial location as
background samples (panels B and D, Additional file 3:
Figure S2). Similar results were found when unweighted
UniFrac was used.
The second pneumotype had high relative abundance
of supraglottic-characteristic taxa (SCT), such as
Prevotella and Veillonella (Figure 4, panels A and C).
We named this group pneumotypeSCT. PCoA of
weighted UniFrac distances indicated that BAL samples
characterized as pneumotypeSCT were in similar spatial
locations as supraglottic samples (panels B and D,
Additional file 3: Figure S2). PneumotypeSCT had
four-fold higher total 16S rRNA gene concentrations
compared with pneumotypeUN (183,312 (72,343-320,442)
vs. 41,300 (22,375-96,000) copies/mL, P= 0.003). The 16S




Figure 4 Clustering analysis of background, supraglotic, and BAL microbiota patterns. (A) Heat map of unsupervised hierarchical
clustering of most abundant OTUs at a genus level (relative abundance ≥5% in any sample) in background and supraglottic samples. Background
microbiome (sterile saline and saline through bronchoscope, see Additional file 1: Figure S1 for details) is enriched with Staphylococcus,
Propionibacterium, and Corynebacterium, while the supraglottic microbiome is enriched with Prevotella and Streptococcus. (B) PCoA analysis based
on weighted UniFrac distances clustered background samples separated from supraglotic samples. (C) Heat map of unsupervised hierarchical
clustering of BAL samples. Never-smokers are indicated with green labels and smokers with blue labels. Dendrogram shows deep cleft that
identified two major BAL microbiomes: one characterized by high relative abundance of Staphylococcus, Propionibacterium, and Corynebacterium
which we called PneumotypeUN and a second with high relative abundance of Prevotella, Veillonella, and Streptococcus (pneumotypeSCT). (D)
PCoA analysis based on weighted UniFrac distances differentiate the same BAL samples in the same two well-defined clusters (never-smokers in
green dots and smokers in blue dots).
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microbiome of smokers had similar distribution along
PCoA as well as α and β diversity (Additional file 4:
Figure S3). Smoking did not have significant impact on
pneumotype allocation.
Background microbiome
Since 16S rRNA from the genus Streptococcus was found
in background, BAL, and supraglottic samples, we evalu-
ated the relative abundances of each Streptococcus OTU in
all samples (Figure 5). Classification of Streptococcus OTU
by Greengenes Blast showed that background samples
were enriched with Streptococcus thermophilus (relative
abundance 0.023 (0.010-0.036)), a known environmentalcontaminant [39]. Similarly, pneumotypeUN had higher
relative abundance of Streptococcus thermophilus than
pneumotypeSCT (0.014 (0.005-0.044)vs. 0.003 (0.002-0.017),
P= 0.04). Conversely, supraglottic samples were enriched
with Streptococcus mitis (relative abundance 0.0520 (range,
0.0084-0.1625)), a well-known member of the oral micro-
biota and an opportunistic pathogen. PneumotypeSCT also
was enriched with Streptococcus mitis (0.0057 (0.0024-
0.0104)vs. 0.0441 (0.0266-0.0617), for pneumotypeUN and
pneumotypeSCT respectively, P<0.0001).
The presence of bacterial DNA in the sterile saline
used to perform the BAL led to the expected presence of
background in each BAL sample. We therefore tested
whether removal of sequences commonly found in the
BA
DC
Figure 5 Classification ofStreptococcusOTUs in background, supraglottic, and BAL microbiota. Twenty-one Streptococcus OTUs were
aligned to the Greengenes database of 16S rRNA sequences. In each case, the top hit (>96%) was used for final classification. Perfect match was
indicated (*) if found. (A) Background samples contained predominantly Streptococcus thermophilus. (B) Supraglottic samples contained
predominantly Streptococcus mitis. (C) Relative abundances of all Streptococcus OTUs in all 29 BAL samples clustered as indicated in Figure 3
(never-smokers indicated with green label and smokers with blue label). PneumotypeUN is enriched with Streptococcus thermophilus while
PneumotypeSCT has higher relative abundances of Streptococcus mitis.
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‘saline OTUs’ (≥1% relative abundance in saline) from BAL
samples did not alter sample allocation in the unsupervised
hierarchical clustering (data not shown). However, subtrac-
tion revealed high relative abundances of Sphingomonas,Tropheryma, Acidovorax, and Asticcacaulis in some
pneumotypeUN samples, but not in pneumotypeSCT sam-
ples. UniFrac distances between pneumotypeUN and saline
(0.72 ± 0.02) were lower than the distance between
pneumotypeSCT and saline (0.78 ± 0.04, P= 0.002), also
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pneumotype 1.
Pneumotype and lung inflammation
Since lymphocytes and neutrophils are recruited into the
alveolar space during inflammation, we used BAL cell
counts as measures of lung inflammation. Compared with
pneumotypeUN, pneumotypeSCT was associated with
higher numbers of lymphocytes (11,130 (4,640-16,069)vs.
23,315 (10,256-47,706) cells/mL for pneumotypeUN and
pneumotypeSCT respectively, P= 0.007) and neutrophils in
BAL (3,333 (1,411-4,327)vs. 4,537 (3,211-8,259) cells/mL,
P= 0.034, Figure 6A and B). We also evaluated eNO
obtained prior to the bronchoscopy as an independent
measure of lung inflammation (Figure 6C). Compared
with pneumotypeUN, pneumotypeSCT was associated with
higher levels of eNO (14.5 (9.0-23.3)vs. 27.5 (15.8-41.5)A
D E
B
Figure 6 Relationship between pneumotype/supraglottic-characterist
neutrophils) and eNO were measured in BAL of asymptomatic subjects (ne
Comparisons of inflammatory cells and eNO between pneumotypeUN and
higher inflammatory BAL cells and higher levels of eNO. (D, E,F) Correlatio
taxa, in BAL in relation to inflammatory cells/eNO (Spearman rho correlatio
inflammatory cells and eNO.ppb, P= 0.022). Since smoking is known to decrease eNO
we investigated whether the association between
pneumotypeSCT and increased eNO was independent of
smoking. First, eNO levels in never-smokers and smokers
were similar (17.8 (10.9-36.0)vs. 20.0 (13.0-32.6), P= 0.71).
Further, using a linear regression model that considered
eNO as dependent variable and smoking and pneumotype
as dichotomized predictors, we found that pneumotypeSCT
was independently associated with eNO (B = 12.3 ppb,
P= 0.028) while smoking was not significantly associated
with levels of eNO (B = 0.5 ppb, P= 0.9). We then evaluated
whether relative abundances of specific supraglottic-
characteristic taxa were associated with lung inflammation.
As shown in Figure 6D, E, and F, the relative abundance of
Veillonella was positively correlated with both BAL
inflammatory cells and eNO. Similarly, relative abun-
dance of Prevotella correlated with BAL inflammatoryF
C
ic taxa and lung inflammation. Inflammatory cells (lymphocytes and
ver-smokers in open circles and smokers in closed circles). (A, B,C)
pneumotypeSCT (Mann–Whitney). PneumotypeSCT was associated with
ns between relative abundance of Veillonella, supraglottic-characteristic
n). Veillonella showed a positive correlation with both BAL
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a pneumotype defined by supraglottic-characteristic taxa
is associated with inflammatory cells in the lung and with
a non-invasive marker of airway inflammation.
Discussion
This paper described distinct microbial communities that
defined two pneumotypes in asymptomatic subjects.
PneumotypeUN had low bacterial load and a taxonomic dis-
tribution similar (although not identical) to the background
microbiome found in sterile saline. PneumotypeSCT had a
higher 16S rRNA gene load and was enriched with
supraglottic taxa such as Prevotella and Veillonella.
PneumotypeSCT subjects had subclinical lung inflammation
with increased BAL inflammatory cells and eNO. These
data suggest an association between a distinct human
microbiome and inflammation in the lung.
Supraglottic secretions have a 50-fold higher 16S rRNA
gene concentration than BAL; therefore, carry-over of oro-
pharyngeal secretions to the lower airways is a major chal-
lenge for bronchoscopy. Prior studies suggest that the
lower airway microbiome have similar microbial compos-
ition to the upper airway, raising concerns for carry-over
of oropharyngeal secretions to the lower airways [5,6,9,10].
The route used for bronchoscopic approach might have
significant impact since the microbiome of the oral and
nasal cavity are different [40,41]. We used the nasal route
because of evidence that nasal brushes have low 16S rRNA
gene concentrations [27]. Our nasal bronchoscopic tech-
nique may have reduced contamination with oral secre-
tions, enabling the uncovering of pneumotypeUN with low
abundance of supraglottic-characteristic OTUs.
Three lines of evidence suggest that pneumotypeSCT
was not due to carry-over of supraglottic taxa during
bronchoscopy. First, had there been carry-over, the
microbiome of first BAL would more closely resemble the
supraglottic microbiome than the second BAL. In fact,
UniFrac distances between supraglottic samples and the
first BAL and second BAL were not different. Second, it is
likely that the increased lymphocytes and neutrophils in
the alveolar space of pneumotypeSCT subjects were almost
certainly present prior to bronchoscopy since cell recruit-
ment into the alveolar space probably requires more time
than the duration of the bronchoscopy procedure. Third,
exhaled NO was increased in pneumotypeSCT patients be-
fore the research bronchoscopy, demonstrating that this
inflammatory phenotype existed prior to bronchoscopy.
In our study population, we found two distinct lung
microbiomes. PneumotypeUN had low 16S rRNA con-
centration, little evidence of supraglottic-characteristic
OTUs and a taxonomic composition similar to the nor-
mal saline used in the research bronchoscopy. These re-
sults differ from recently published series in which oral
microbiota was present in most of the BAL samples[6,11]. Technical differences between the studies may ac-
count for this discrepancy, since we aimed to minimize any
potential carry-over with our bronchoscopic technique.
The presence of microbial DNA in sterile saline made it dif-
ficult to ascertain which bacterial OTUs, if any, were
present in the lung of pneumotypeUN subjects prior to the
bronchoscopy. To reduce background noise, we subtracted
saline-characteristic OTUs from the BAL. This revealed
the presence of Sphingomonas, Tropheryma, Acidovorax,
and Asticcacaulis in some pneumotypeUN but not in
pneumotypeSCT samples. Our finding of Tropheryma in 2/
16 patients in pneumotypeUN (relative abundance of 0.02 in
the never-smoker and 0.11 in the smoker) is consistent with
a recent report describing Tropheryma in the lower airways
of 12% to 40% of normal subjects [10]. Studies with larger
cohorts using low contamination bronchoscopic tech-
niques, deeper sequencing, and bioinformatic source track-
ing approaches are needed to better describe pneumotype
(s) in subjects with low bacterial rRNA gene concentrations
[42,43].
Our clustering analysis allowed us to define
pneumotypeSCT, which was present in 8/20 smokers (40%)
and 4/9 never-smokers (45%). Prior investigations have at-
tributed the observed increased abundance of oral-
characteristic taxa in the lower airways to microaspiration
or carry-over. This study extends prior investigations by
showing that systematic carry-over does not occur and that
the increased abundance of supraglottic-characteristic flora
in pneumotypeSCT was associated with increased BAL neu-
trophils, lymphocytes, and eNO. Since pneumotypeSCT also
has high relative abundance of Prevotella/Veillonella and
high inflammatory cells in the lung, there may be a com-
mon link between microaspiration of Prevotella/Veillonella
and inflammation. Importantly, the BAL cell differentials
were normal in both never-smokers and smokers,
suggesting that differences in lung inflammation between
pneumotypeUN and pneumotypeSCT represent subclinical
variation.
Data suggest that smoking alters the upper airway
microbiome leading to enrichment with Veillonella [11,41].
Persistent microorganisms contribute to pulmonary in-
flammation in current and former smokers with advanced
COPD [44]. Similar to recent studies [11], we found no
significant difference in α or β diversity between never-
smokers and smokers. It is possible that increasing the
sequencing depth would reveal smoking or early COPD-
specific microbes present at lower relative abundance. It
also is possible that investigation of larger cohorts would
reveal more substantial microbiome differences between
these never-smokers and smokers. However, perturbation
of the lung microbiome may occur only in more advanced
disease due to progressive microaspiration and impaired
bacterial clearance. Alteration of the lung microbiome also
may follow treatments for COPD with antibiotics and/or
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ing cohort or the absence of recent drug treatment may ac-
count for the differences between our observations and the
prior reports [7,8,21].
The association between specific pneumotype and airway
inflammation was evaluated utilizing eNO based on prior
observations describing increased eNO in pulmonary in-
fections and following lipopolysaccharide administration
[45-47]. Our results extend these observations by demon-
strating that elevated eNO may occur in association with a
specific pneumotype even in the absence of overt pneumo-
nia. Increased eNO levels were associated with both
pneumotypeSCT and enrichment with supraglottic taxa
such as Veillonella suggesting that the presence of subclin-
ical inflammatory changes may occur in response to
pathogen-associated molecules. Although smoking may in-
fluence eNO levels, in our cohort, the association of in-
creased eNO with pneumotypeSCT was independent of
smoking history [48,49]. Further investigation will be
needed to determine whether a change in pneumotype
leads to increase levels of eNO. The enhanced subclinical
inflammation observed in pneumotypeSCT may warrant in-
vestigation into whether this pneumotype is associated
with early physiologic markers of airway dysfunction in
smokers at risk for COPD.
This study has several limitations. DNA molecular tech-
niques cannot determine bacterial viability. Further, the
association between inflammation and supraglottic-
characteristic taxa in the lower airways does not imply that
Prevotella and Veillonella in the lower airways cause in-
flammation. Additionally, the relatively small sample size,
and the depth of sequencing may have prevented us from
observing subtle but potentially important differences
between smokers and never-smokers. Finally, our cross-
sectional design does not allow us to measure the tem-
poral stability of the lower airway microbiome. Evaluation
of the impact of pneumotype resilience on lung inflamma-
tion is important to understand the potential role of the
lung microbiome in the development of lung injury.
Conclusions
We observed that a pneumotype enriched with
supraglottic-characteristic bacteria Prevotella and Veillonella
was associated with higher inflammatory markers, consistent
with the hypothesis that oral bacteria in the lung produce
subclinical pulmonary inflammation. In this relatively healthy
cohort, the association between microbiome and lung
inflammation exists in asymptomatic subjects, both never-
smokers and smokers. In advancing COPD, mucocilliary dys-
function worsens and the risk for microaspiration increases
[50,51]. This could introduce high relative abundance of oral
flora into the lower airways leading to pneumotypeSCT and
its associated increased inflammation. In addition, it is plaus-
ible that the progressive immune dysfunction of COPDchanges the lung microbiome [52,53]. Further understanding
of the association between pneumotypes and pulmonary in-
flammation will be required to relate the above observations
to the development of lung diseases and the potential impact
of antibiotics.
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Additional file 1: Figure S1. Sampling scheme of background,
supraglottic and BAL. Thirty-four background samples were obtained
from either sterile saline used for BAL (n = 6) or saline passed through
bronchoscope’s suctioning channel prior to procedure (n = 28). All
bronchoscopies were performed nasally. In the 15 of the 29 studied
subjects where supraglottic samples were obtained, we used a separate
bronchoscope (Bronchoscope 1). This bronchoscope was passed without
suctioning until vocal cords were visualized, at which time sample was
obtained and then scope was withdrawn. The supraglottic sample was
obtained by flushing 10 cc of normal saline through this bronchoscope.
For all BAL samples, a separate bronchoscope (Bronchoscope 2) was
passed without suctioning until wedged, at which time BAL was
obtained. In the subset of 15 of the 29 studied subjects, BAL was
differentially obtained from lingula and right middle lobe to evaluate for
carry-over of supraglotic microorganisms. For rest of analysis, BAL obtained
in the lingula and right middle lobe was pooled in all 29 subjects.
Additional file 2: Online supplement: Enrichment of lung
microbiome with supraglottic taxa is associated with increased
pulmonary inflammation.
Additional file 3: Figure S2. Evaluation of BAL microbiome compared
with background and supraglottic microbiome in Principal Coordinate
Analysis (PCoA). PCoA (x axis PC1 = 26.8% vs. y axis PC2 = 8.56%) based
on weighted UniFrac distances for microbiome of background (black),
BAL (never-smokers in green, smokers in blue), and supraglottic area
(red). BAL samples had the highest variability as expressed by their
distribution along PC1. Some BAL samples overlapped with background
microbiome whereas others overlapped with supraglottic microbiome.
(A) PCoA weighted by relative abundances of Propionibacterium (black
boxes) showed higher relative abundances for this taxa in BAL samples
that overlapped with background samples. (B,C) PCoA weighted for
relative abundances of Prevotella and Veillonella (black boxes) showed
higher relative abundances for these taxa among BAL samples that
overlapped with supraglottic samples.
Additional file 4: Figure S3. Comparison between the lung
microbiome of never-smokers and asymptomatic smokers. (A) PCoA
based on weighted UniFrac distances for never smokers and smokers.
PC1, PC2, and PC3 represent 43.7% of the variability on the data. Data
shows complete overlapping of circle of inertia between smokers and
never smokers. (B) α-diversity, expressed as richness, was similar in never-
smokers and smokers. (C) β–diversity, based on weighted UniFrac
distance for pairwise comparisons, among and between never-smoker
and smoker subjects also was not significantly different (mean±SEM)
between the groups.Abbreviations
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